NervGen Pharma stock forecast
NervGen Pharma (9UA) Stock Forecast & Price Target
9UA Analyst Ratings
9UA Stock 12 Month Forecast
Average Price Target
€9.07▲(446.48% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Marc Goodman | Leerink Partners | €9.07 | buy | 446.48%Upside | Reiterated | 10/01/26 | ||
| Joseph Thome | TD Cowen | ― | buy | ― | Reiterated | 08/13/26 | ||
| Ram Selvaraju | H.C. Wainwright | €16.33→€13.61 | buy | 719.71%Upside | Reiterated | 07/14/26 | ||
| Justin Keywood | Stifel Nicolaus | €5.44 | buy | 227.89%Upside | Reiterated | 05/21/26 | ||
| Elemer Piros | Lucid Capital | €16.33 | buy | 883.66%Upside | Initiated | 04/15/26 | ||
| Andre Uddin | Research Capital | €4.99 | buy | 200.56%Upside | Reiterated | 04/10/26 | ||
| Michael Okunewitch | Maxim Group | €9.07→€10.89 | buy | 555.77%Upside | Assigned | 04/09/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Marc GoodmanLeerink Partners | BuyReiterated€9.07 | 10/01/26 | 446.48%Upside | ||
| Joseph ThomeTD Cowen | BuyReiterated | 08/13/26 | ― | ||
| Ram SelvarajuH.C. Wainwright | BuyReiterated€16.33→€13.61 | 07/14/26 | 719.71%Upside | ||
| Justin KeywoodStifel Nicolaus | BuyReiterated€5.44 | 05/21/26 | 227.89%Upside | ||
| Elemer PirosLucid Capital | BuyInitiated€16.33 | 04/15/26 | 883.66%Upside | ||
| Andre UddinResearch Capital | BuyReiterated€4.99 | 04/10/26 | 200.56%Upside | ||
| Michael OkunewitchMaxim Group | BuyAssigned€9.07→€10.89 | 04/09/26 | 555.77%Upside |
Best Analysts Covering NervGen Pharma
Copying Justin Keywood's trades and holding each position for 3 Months would result in 36.36% of your transactions generating a profit, with an average return of -11.20% per trade.
Copying Justin Keywood's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +9.51% per trade.
Copying Justin Keywood's trades and holding each position for 2 Years would result in 18.18% of your transactions generating a profit, with an average return of -7.85% per trade.
9UA Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 2 | 1 | 1 |
| Buy | 1 | 2 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 6 | 6 | 3 | 2 | 1 |
In the current month, 9UA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 9UA average Analyst price target in the past 3 months is 9.07.
9UA Financial Forecast
9UA Earnings Forecast
Next quarter’s earnings estimate for 9UA is -EUR 0.11 with a range of -EUR 0.13 to -EUR 0.09. The previous quarter’s EPS was -EUR 0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
9UA Sales Forecast
Next quarter’s sales forecast for 9UA is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

